ClinicalTrials.gg

Program

ferric carboxymaltose

Also written as “Ferric Carboxymaltose (FCM)”, “Ferric carboxymaltose” and “Injectafer”.

Its studies are mostly in Anemia, Iron-Deficiency · Anemia · Iron Deficiencies · Restless Legs Syndrome · Heart Failure, led by 4 companies.

Furthest: phase 4, since Sep 23, 201346 company-led studies, 1 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Daiichi Sankyo280 open or runningphase 4since Sep 23, 2013Apr 20, 2006none ahead
CSL140 open or runningphase 4since Mar 29, 2010Aug 24, 2007none ahead
Sichuan Huiyu Pharmaceutical31 open or runningphase 1since Sep 27, 2023Sep 27, 2023none ahead
Novartis10 open or runningphase 1since Dec 5, 2017Dec 5, 2017none ahead

Also a collaborator on its studies: Suzhou Guochen Biotechnology, Boji Medical Technology, ClinStar, Cytel, Tigermed Consulting, Pierrel Research Europe, ICON Clinical Research, Parexel and SGS.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 32 studies since Apr 20, 2006.

  1. Mar 27, 2015Phase 2 study in Anemia, Iron-DeficiencyDaiichi Sankyo · NCT02410213 · 35 enrolled · Poland, Russian Federation
  2. Apr 1, 2015Phase 2 study in Iron DeficienciesDaiichi Sankyo · NCT02409459 · 81 enrolled · United States
  3. May 21, 2015Phase 3 study in NeoplasmsDaiichi Sankyo · NCT02453334 · 244 enrolled · United States
  4. Jun 30, 2016Phase 2 study in Restless Legs SyndromeDaiichi Sankyo · NCT02826681 · 70 enrolled · United States
  5. Oct 14, 2016Phase 4 study in Iron DeficienciesCSL · NCT02937454 · 1,132 enrolled · Argentina, Brazil, Croatia and more
  6. Jan 25, 2017Phase 3 study in Heart FailureDaiichi Sankyo · NCT03037931 · 3,065 enrolled · United States, Australia, Bulgaria and more
  7. Dec 5, 2017Novartis's first study: phase 1 study in Anemia, Iron-DeficiencyNew to NovartisNovartis · NCT03399084 · 71 enrolled · United States
  8. Apr 17, 2018Phase 3 study in Anemia, Iron-DeficiencyDaiichi Sankyo · NCT03523117 · 79 enrolled · United States
  9. Jun 22, 2018Phase 3 study in Anemia, Iron-DeficiencyCSL · NCT03591406 · 371 enrolled · China
  10. Feb 12, 2020Phase 3 study in Anemia, Iron-DeficiencyDaiichi Sankyo · NCT04269707 · 7 enrolled · United States
  11. Nov 2, 2020Phase 2 study in Anemia, Iron-DeficiencyDaiichi Sankyo · NCT04968379 · United States
  12. Sep 27, 2023Sichuan Huiyu Pharmaceutical's first study: phase 1 study in Iron DeficienciesNew to Sichuan Huiyu PharmaceuticalSichuan Huiyu Pharmaceutical · NCT06080555 · 84 enrolled · China
  13. Mar 20, 2025Phase 1 study in Healthy AdultSichuan Huiyu Pharmaceutical · NCT06895993 · 84 enrolled · China
  14. May 12, 2026Phase 1 study in Healthy AdultSichuan Huiyu Pharmaceutical · NCT07606105 · 70 planned · China

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 46 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT07606105Healthy Adult · China1RecruitingSichuan Huiyu PharmaceuticalAug 26, 202670
NCT06895993Healthy Adult · China1CompletedSichuan Huiyu PharmaceuticalMay 8, 202584
NCT06080555Iron Deficiencies · China1CompletedSichuan Huiyu PharmaceuticalJan 22, 202484
NCT04968379Anemia, Iron-Deficiency · United States2WithdrawnDaiichi SankyoOct 8, 20240
NCT04269707Anemia, Iron-Deficiency · United States3CompletedDaiichi SankyoDec 30, 20207
NCT03591406Anemia, Iron-Deficiency · China3CompletedCSLFeb 25, 2019371
NCT03523117Anemia, Iron-Deficiency · United States3CompletedDaiichi SankyoDec 22, 202079
NCT03399084Anemia, Iron-Deficiency · United States1CompletedNovartisJan 15, 201971
NCT03037931Heart Failure · United States, Australia, Bulgaria and more3CompletedDaiichi SankyoFeb 2, 20233,065
NCT02937454Iron Deficiencies · Argentina, Brazil, Croatia and more4CompletedCSLJul 21, 20201,132
NCT02826681Restless Legs Syndrome · United States2TerminatedDaiichi SankyoSep 4, 202170
NCT02453334Neoplasms · United States3CompletedDaiichi SankyoJan 2018244
NCT02409459Iron Deficiencies · United States2CompletedDaiichi SankyoOct 201581
NCT02410213Anemia, Iron-Deficiency · Poland, Russian Federation2CompletedDaiichi SankyoJan 22, 201735
NCT02397057Restless Legs Syndrome · United States3CompletedDaiichi SankyoJan 2018209
NCT02086968Iron Deficiency Anemia Secondary to IBD or Gastric Bypass4CompletedDaiichi SankyoJul 16, 2016198
NCT01950247Anemia, Iron-Deficiency4CompletedDaiichi SankyoMay 20, 20151,025
NCT01453608Iron Deficiencies · Poland, Russian Federation4CompletedCSLFeb 2014304
NCT01394562Iron Deficiencies · Netherlands3CompletedCSLMay 2016174
NCT01382901Restless Legs Syndrome2CompletedDaiichi SankyoJul 200745
NCT01290315Anemia, Iron-Deficiency · United States2CompletedDaiichi SankyoMar 201349
NCT01307007Anemia, Iron-Deficiency2CompletedDaiichi SankyoMay 201169
NCT01131624Anemia · Australia, Germany, Sweden and more3CompletedCSLMay 2014252
NCT01110356Iron Deficiencies · Austria4CompletedCSLOct 2011294
NCT01101399Anemia, Iron-Deficiency · Germany, Sweden3CompletedCSLNov 201219
NCT01100879Anemia, Iron-Deficiency · France, Greece4TerminatedCSLJul 20113
NCT00994318Anemia, Iron-Deficiency · United States, Australia, Austria and more3CompletedCSLFeb 2013626
NCT00982007Anemia, Iron-Deficiency · United States3CompletedDaiichi SankyoMar 2011997
NCT00981045Anemia, Iron-Deficiency · United States3CompletedDaiichi SankyoJul 20112,561
NCT00882414Thrombocytosis · Austria2TerminatedCSLJan 201026
NCT00821717Iron Deficiencies · Denmark, France, Germany and more3TerminatedCSLOct 200935
NCT00810030Inflammatory Bowel Diseases · Austria3CompletedCSLDec 2009484
NCT00810004Iron Deficiencies · Russian Federation3CompletedCSLOct 2010245
NCT00740246Anemia · United States3CompletedDaiichi SankyoFeb 2006594
NCT00704353Anemia · United States3CompletedDaiichi SankyoJul 2009735
NCT00704028Anemia · United States3CompletedDaiichi SankyoJan 2010161
NCT00703937Anemia · United States3CompletedDaiichi SankyoJul 2009708
NCT00685815Restless Legs Syndrome · United States2CompletedDaiichi SankyoDec 201012
NCT00548860Anemia · United States3CompletedDaiichi SankyoMar 20092,018
NCT00548691Anemia · United States3CompletedDaiichi SankyoJan 2009513
NCT00520780Iron Deficiencies · Argentina, Germany, Greece and more3CompletedCSLJul 2009456
NCT00396292Anemia · United States3CompletedDaiichi SankyoNov 2005361
NCT00395993Anemia · United States3CompletedDaiichi SankyoApr 2006456
NCT00354484Anemia · United States3CompletedDaiichi SankyoDec 2006291
NCT00317239Anemia · United States3CompletedDaiichi SankyoFeb 2007255
NCT00317226Anemia · United States3CompletedDaiichi SankyoMar 2007145

How it is read

Names in the registry

  • “Ferric Carboxymaltose (FCM)”, 13 entries
  • “Ferric carboxymaltose”, 8 entries
  • “Injectafer”, 5 entries
  • “Ferric Carboxymaltose”, 5 entries
  • “Ferric Carboxymaltose Injection”, 3 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.
ferric carboxymaltose (Daiichi Sankyo): development program | ClinicalTrials.gg